Package 65219-257-01

Brand: ephedrine sulfate

Generic: ephedrine sulfate
NDC Package

Package Facts

Identity

Package NDC 65219-257-01
Digits Only 6521925701
Product NDC 65219-257
Description

25 VIAL, GLASS in 1 CARTON (65219-257-01) / 1 mL in 1 VIAL, GLASS (65219-257-00)

Marketing

Marketing Status
Marketed Since 2020-10-31
Brand ephedrine sulfate
Generic ephedrine sulfate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "453036d8-bcc1-45a2-a905-edb03a8b743a", "openfda": {"upc": ["0365219257004"], "unii": ["U6X61U5ZEG"], "rxcui": ["1116294"], "spl_set_id": ["5ecd9746-25c7-4bd4-9503-eb97e7db5aa5"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, GLASS in 1 CARTON (65219-257-01)  / 1 mL in 1 VIAL, GLASS (65219-257-00)", "package_ndc": "65219-257-01", "marketing_start_date": "20201031"}], "brand_name": "Ephedrine Sulfate", "product_id": "65219-257_453036d8-bcc1-45a2-a905-edb03a8b743a", "dosage_form": "INJECTION", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Releasing Agent [EPC]", "alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]"], "product_ndc": "65219-257", "generic_name": "Ephedrine Sulfate", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ephedrine Sulfate", "active_ingredients": [{"name": "EPHEDRINE SULFATE", "strength": "50 mg/mL"}], "application_number": "ANDA209646", "marketing_category": "ANDA", "marketing_start_date": "20201031", "listing_expiration_date": "20261231"}